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Abstract 
In order to clarify the mechanism of proteinuria in diabetic 
nephropathy, ultrastructural changes of the glomerular basement 
membrane (GBM) in patients with diabetic nephropathy were exam-
ined by electron microscopy using our newly devised "tissue 
negative staining method''. The normal human GBM showed a fine 
meshwork structure consisting of fibrils forming the small pores. 
The diameter of these pores was slightly smaller than that of 
human albumin molecules. The GBM in patients with diabetic 
nephropathy showed irregular thickening. At higher magnifica-
tion, hitherto unknown cavities and tunnel structures, which were 
not seen in nor111al controls, were observed in the thickened GBM. 
In some portions, these cavities presented a honeycomb-like 
appearance. The diameters of the cavities and tunnels were far 
larger than -the dimensions of albumin molecules. These enlarged 
structures are believed to allow seru1n protein molecules to pass 
through the GBM from the capillary lumen to the urinary space. 
These results suggest that the cause of massive proteinuria in 
diabetic nephropathy is the disruption of the size barrier of the 
GBM. 
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Ul -trastructure 
2 
Introduction 
In diabetes mellitus, nephropathy is one of the major com-
plication which determines the prognosis. Clinically, the pa-
tients with diabetes mellitus often manifest nephrotic syndrome 
and renal failure. Histologically, characteristic changes of 
diabetic nephropathy are thickening of the glomerula r basement 
membrane (GBM) and increase of mesangial matrix. However, the 
mechanism of proteinuria in diabetic nephropathy is unclear. The 
ultrastructural changes in molecular level of the GBM also have 
not been clarified. 
Glomerular ultrafiltration is considered to occur in the GBM 
(1-3). In 1977, we observed purified unfixed bovine GBM by elec-
tron microscopy after routine negative staining and demonstrated 
a three-dimensional meshwork structure of the GBM consisting of 
fibrils that formed pores with dimensions slightly less than 
those of albumin molecules (4-6). This fine meshwork structure 
was believed to play a critical role as a size barr ier against 
serum protein molecules in ultrafiltration in the glomerulus. 
More recently, we developed a "tissue negative staining method" 
that permitted observation of the molecular-level ultrastructures 
in situ of ultrathin sections that had been routinely prepared 
for electron microscopy (7,8). In this study we demonstrated the 
existence of tunnel structures and cavities in the GBM of pa-
tients with membranous nephropathy and lupus nephritis. These 
structures may bear a causal relationship to free passage of 
plasma protein through the GBM. 
In this study, in order to clarify the mechanism of protei-
nuria in diabetic nephropathy, the ultrastructure of the GBM in 
3 
patients with diabetic nephropathy manifesting nephrotic syndrome 
was examined by means of our tissue negative staining method. 
Subjects and Methods 
Subjects 
The specimens were obtained by renal biopsies of three 
patients (cases 1-3) with non-insulin dependent diabetes mellitus 
manifesting nephrotic syndrome who excreted more than 3.5 g 
protein into their urine per day. All of these specimens were 
examined by the routine methods including immunofluorescence, 
light and electron microscopic studies, and showed uniform thick-
ening of the GBM (Fig. 1), nodular lesions, and exudative or 
hyalinosis lesions. As normal controls, specimens from normal 
portions of the kidneys of three patients operated on due to 
renal carcinoma, and a specimen by renal biopsy of a patient with 
urological bleeding were used. We confirmed that these normal 
controls have no pathological change by the same routine meth-
ads. Thickness of the normal GBM and diabetic GBM were about 300 
nm and 741.5±152.4 nm, respectively. 
Tissue negative staining 
The tissue negative staining was performed as previously 
described by us (7,8). Briefly, the specimens were fixed in 2.5% 
glutaraldehyde, post-fixed in 1% Os04 in 0.1 M cacodylate buffer 
(pH 7 . 4), and embedded in Epon 812. After embedding, removal of 
Epon 812 was performed by a modification of Lane's method (9). 
After hydrophilization, a drop of 1% phosphotungstic acid (pH 
7.3) was placed on the section, and excessive solution was 
blotted with a blotting paper. These sections were observed and 
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photographed using transmission electron microscope (Hitachi H-
700) at an acceleration voltage of 75 KV at magnifications of 
2,000 to 30,000. 
Morphometric study 
Measurement of the diameters of small pores and fibrils was 
performed at 50 sites on electron micrographs magnified 300,000 
times. The short diameters and long dimensions of pores were 
measured from one point of the internal surface of the fibril to 
the opposite point using a loupe with a scale. The short diamet-
er of the pores was measured first and the long dimension was 
measured perpendicular to the short diameter. 
To estimate the degree of the structural changes, the 5 
perpendicular lines across the GBM in 5 glomeruli were drawn at 
random on electron micrographs of the capillary (x 60,000), and 
the sum of total diameters of all pores and cavities on those 
lines was measured. 
Results 
Normal human GBM. 
The normal human GBM showed a definite three-dimensional 
meshwork structure resembling a crystal lattice (Fig. 2). This 
meshwork consisted of fine fibrils forming numerous nearly uni-
form-sized round or oval pores. This structure was observed all 
over the GBM, and seemed to be uniform almost everywhere in the 
GBM. Subepithelial space and subendothelial spaces were clearly 
observed. At higher magnification, many small pores were demon-
strated more clearly (Fig. 3). The short diameter of the pores 
was 2.5±0.4nm (mean± SO) and long dimension was 2.8±0.5nm. The 
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diameter of the fibrils was 1.9±0.4nm. 
GBM in patients with diabetic nephropathy 
The GBM in patients with diabetic nephropathy showed 
irregular thickening (Fig. 4). Numerous large round or irregu-
larly shaped defects that were albe to be described as cavities 
and tunnels were observed in thickened GBM. Some of these cavi-
ties seem~d to be arranged in layers which were located almost 
parallel to the edge of the GBM. At higher magnification (Fig. 
5,6,7), in some portions of thickened GBM, many cavities had 
aggregated and showed honeycomb-like appearance. The diameters 
of the cavities and tunnels were approximately 10-50 nm. In the 
morphometric study, the sum of total diameters of pores, cavities 
and tunnels on the perpendicular lines across the GBM were 
56. 6 ±.0. 4 nm ( mean:tSD) per 100 nm GBM in normal human specimens, 
66.3~1.8 nm in case 1, 64.0±3.5 nm in case 2, 70.6±3.7 nm in case 
3 per 100 nm GBM in the specimens from diabetic nephropathy 
patients (Table 1). This value of diabetic nephropathy was 
significantly larger than that of normal controls 
Wilcoxon test). 
DISCUSSION 
(p<O.Ol, 
Patients with diabetic nephropathy often manifest nephrotic 
syndrome. Morphologically, the characteristic changes of the 
glomerulus in patients with diabetic nephropathy are thickening 
of the GBM and mesangial matrix expansion. 
The GBM is believed to be the main filtration barrier 
against serum protein n1olecules in the glomerulus (1,2). Con-
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cerning the ultrastructure of the GBM, we observed purified GBM 
by routine negative staining method and demonstrated the fine 
meshwork consisted of fibrils in the GBM as a schematic represen-
tation in Fig.8(4-6). Numerous small pores about 3 nm in diameter 
were present in the meshwork structure. 
aggregated to form larger dark spots. 
Some of the pores had 
These spots resembled 
irregular bunches of grapes and were less well-defined than the 
cavities and tunnels. We proposed that this structure functions 
as the size barrier in ultrafiltration in the glomerulus. 
The major components of the GBM is type IV collagen, laminin 
and heparan sulfate proteoglycan. Timpl et al.(lO) and Yurchenco 
et al.(ll) reported that type IV collagen forms a meshwork of 
irregular polygons. We also demonstrated that this meshwork 
structure of the GBM was composed of type IV collagen by immunoe-
lectron microscopy after chemical treatment (12). 
Recently, we established the tissue n gative staining method 
which enables the observation of structur s at the molecular 
level in situ (7,8). We observed the morphological changes of 
the GBM in patients with nephrotic syndrome by this method and 
demonstrated the presence of the cavities and the tunnel struc-
tures in the GBM in patients with membranous nephropathy and 
lupus nephritis(8). The diameters of these cavities and tunnels 
were far larger than the diameter of human albumin 
molecules(Fig.9)(8). Thus, we proposed that these pathological 
changes of the GBM caused proteinuria(7,8). 
In diabetic nephropathy, it is reported that an increased 
production of glomerular extracellular matrix components and a 
decreased turnover of extracellular matrix presumably leads to a 
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thickening of the GBM and expansion of the mesangial matrix (13). 
It is also reported that non-enzymatic glycation interferes with 
the interaction of matrix components (14). Biochemical study 
indicated that heparan sulfate proteoglycan (HS-PG) decreased and 
type IV collagen increased in the GBM in diabetic nephropathy. 
Beisswenger and Spiro (15) found increased levels of hydroxypro-
line and hydroxylysine contents in diabetic GBM and Karttunen et 
al. found increased levels of extractable type IV collagen (16). 
Rohrbach et al. reported that the HS-PG was reduced in EHS(Engel-
breth-Holm,Swarm) tumors implanted in diabetic mice (17). They 
inferred that the loss of proteoglycans might lead to an in-
crease in the porosity of the structure of the GBM with compensa-
tory increase in type IV collagen and laminin. Immunohistochemi-
cal study suggested that type IV collagen was increased in the 
glomerulus of the patients with diabetic nephropathy (18). Our 
recent immunoelectron microscopic study of the diabetic GBM 
demonstrated the decreased density of type IV collagen in spite 
of an increase in the absolute number of gold particles reacting 
with type IV collagen due to the thickening of the GBM (19). 
In our present study, we demonstrated the hitherto unknown 
morphological changes of the GBM in patients with diabetic neph-
ropathy by our tissue negative staining method. Numerous large 
round or irregular defects formed the cavities and tunnel struc-
ture. The diameter of these structures are 10-50 nm. The human 
albumin molecule has a molecular weight of 66,248 and a prolate 
ellipsoid with a short axis of 3.8 nm and a long axis of 15.0 nm 
(20). The dimensions of albumin molecule are much smaller than 
those of the cavities and tunnels in the GBM of diabetic pa-
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tients. This discrepancy in size allows the serum albumin 
molecule and other larger serum protein molecules to pass across 
the GBM in diabetic nephropathy. These changes were not observed 
in normal GBM. In addition, in patients with diabetic nephro-
pathy, the ratio of total diameters of small pores, cavities and 
tunnels to the thickness of the GBM was significantly larger 
than that of normal GBM. These results indicate that the disrup-
tion of size barrier of the GBM leads to proteinuria in patients 
with diabetic nephropathy. As the ratio increases, the total 
amount of protein in proteinuria appears to increase. Although 
·the cause of these structural changes is unclear, non-enzymatic 
glycation may interfere the formation of normal meshwork struc-
ture of type IV collagen molecules. In order to produce protei-
nuria by this mechanism it is necessary that the cavities and 
tunnels continue throughout the entire GBM from the inner surface 
to the outer surface. In membranous nephropathy, the nephrotic 
tunnels obviously penetrated the entire GBM(B). In diabetic GBM, 
these findings have not yet been demonstrated. In the future, 
serial sections should be used in addition to the tissue negative 
staining method to clarify these changes. 
We conclude that the disruption of size barrier of the GBM 
permits massive proteinuria in pa ·tients with diabetic nephro-
pathy. 
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Legends to figures 
Fig. 1 Ultrathin section of glomerulus in the patient with 
diabetic nephropathy (case 1). Thickened glomerular basement 
membrane (G) and collapsed capillary lumen (CL) are observed. 
Bar=l~m. x4,000. 
Fig. 2 Tissue negative staining of the capillary wall in normal 
human kidney. Epithelial cell (EP), the GBM (G), endothelial 
cell(ED), subepithelial space (long arrow), subendothelial space 
(short arrow) are clearly seen. Bar=lOOnm. x40,000. 
Fig. 3 Tissue negative staining of the capillary wall in normal 
human GBM at higher magnification. Many small pores (arrowheads) 
are demonstrated clearly. Bar=lOnm. x300,000. 
Fig. 4 Tissue negative staining of the GBM in diabetic nephro-
pathy (case 3). Numerous large round or irregularly shaped de-
fects are observed. These cavities (arrowheads) is approximately 
10-50 nm in diameter. Bar=lOOnm. x20,000. 
Fig. 5 Tissue negative staining of the GBM in diabetic nephro-
pathy (case 3) at higher magnification. Many cavities are aggre-
gated and show a honeycomb-like appearance (arrowheads). 
Bar=lOOnm. x60,000. 
Fig. 6 Tissue negative staining of the GBM in diabetic nephro-
pathy (case 1) at higher magnification. Numerous cavities 
(arrowheads) are also observed. Bar=lOOnm. x60,000. 
Fig. 7 Tissue negative staining of the GBM in diabetic nephro-
pathy (case 1) at higher magnification. Many large cavities 
(arrowheads) are clearly seen in the thickened GBM. Bar=lOOnm. 
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x60,000. 
Fig. 8 The schema of albumin molecules and molecular sieve of 
normal GBM. 
Fig. 9 The schema of the mechanism of proteinuria. Albumin 
molecules and the enlargement of molecular sieve. 
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Table 1 The sum of total diameters of the pores, cavities and tun-
nels, and urine protein volume per day of the patients and control. 
Total diameter of the 
pores, cavities and 
tunnelsb (nm/lOOnm) 
Urine protein per 
dayc (g/day) 
CASE l 
66.3±1.6* 
4.3±0.8 
CASE 2 
64.0±3.5* 
3.6±1.2 
All results are expressed as the mean±SD. 
CASE 3 
70.6±3.7* 
9.3±2.2 
*; Significantly different from control (p<0.01). 
NORMAL 
CONTROL a 
56.6±0.4 
<0.1 
a: Specimens from normal portions of the kidneys of the three pa-
tients operated on due to renal carcinoma, and a specimen by renal 
biopsy of a patient with urological bleeding. 
b: The sum of total diameters of all pores, cavities and tunnels on 
the five perpendicular lines across the GBM on electron micrographs 
(x60,000) were measured. 
c: Average urine protein volumes per day during two weeks before 
renal biopsy. 
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